Ureteral stents: A novel risk factor for polyomavirus nephropathy

Transplantation

Volumn 84, Issue 3, 2007, Pages 433-436

  Thomas, Abraham ^a   Dropulic, Lesia K ^a   Rahman, M Hafizur ^a,b   Geetha, Duvuru ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Polyomavirus nephropathy; Renal transplant; Risk factors

Indexed keywords

TACROLIMUS;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MALE; POLYOMAVIRUS NEPHROPATHY; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; RISK FACTOR; URETER INJURY; URETER STENT; VIRUS INFECTION;

ADULT; AGED; BIOPSY; CASE-CONTROL STUDIES; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TREATMENT OUTCOME; URETER;

EID: 34547923167     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000269616.21698.10     Document Type: Article

References (14)

1. Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease. J Am Soc Nephrol 1999; 10: 1080.
2. Binet I, Nickeleit V, Hirsch HH. Polyomavirus infections in transplant recipients. Curr Opin Organ Transplant 2000; 5: 210.
3. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nepho. 2002; 13: 2145.
4. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus BK type replication and nephropathy in renal transplant recipients. N Engl J Med 347; 488.
5. Awadalla Y, Randhawa P, Ruppert K, Zeevi A, Duquesnoy RJ. HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am J Transplant 2004; 4: 1691.
6. Smith JM, McDonald RA, Finn LS, Healey PJ, Davis CL, Limaye AP. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant 2004; 4: 2109.
7. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582-594.
8. Nickeleit V, Hirsch HH, Zeiler M, et al. BK virus nephropathy in renal transplant-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000; 15: 324.
9. Fishman JA. BK virus nephropathy-adding insult to injury. N Engl J Med 2002; 347: 527.
10. Atencio IA, Shadan FF, Zhou XJ, Vaziri ND, Villarreal LP. Adult mouse kidneys become permissive to acute polyoma virus infection and reactivate persistent infections in response to cellular damage and regeneration. J Virol 1993; 67: 1424.
11. Atencio IA, Villarreal LP. Polyomavirus replicates in differentiating but not in proliferating tubules of adult mouse polycystic kidneys. Virology 1994; 201: 26.
12. Cormio L, Talja M, Koivusalo A, et al. Biocompatibility of various indwelling double J stents. J Urol 1995; 153: 494.
13. Marx M, Bettman M, Bridge S, Brodsky G, Boxt LM, Richie JP. The effect of various indwelling catheter materials on the normal canine ureter. J Urol 1988; 139: 180.
14. Lumiaho J, Heino A, Pietilainen T, et al. The morphological in situ effects of a self-reinforced bioabsorbable polylactide (SR-PLA96) ureteric stent: An experimental study. J Urol 2000; 164: 1360.